Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endurant Evo US Clinical Trial

NCT02393716 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT02393716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02393716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endurant Evo US Clinical Trial
Lead sponsor
Medtronic Cardiovascular
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2015
Completion date
June 25, 2021
Enrollment
139 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

aaa, abdominal aortic aneurysm